- Home
- ADCT vs ONL Comparison
ADCT vs ONL Comparison
Compare ADCT & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- ONL
- Stock Information
- Founded
- ADCT 2011
- ONL 2021
- Country
- ADCT Switzerland
- ONL United States
- Employees
- ADCT N/A
- ONL N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- ONL Real Estate Investment Trusts
- Sector
- ADCT Health Care
- ONL Real Estate
- Exchange
- ADCT Nasdaq
- ONL Nasdaq
- Market Cap
- ADCT 143.1M
- ONL N/A
- IPO Year
- ADCT 2020
- ONL N/A
- Fundamental
- Price
- ADCT $1.49
- ONL $2.16
- Analyst Decision
- ADCT Strong Buy
- ONL Hold
- Analyst Count
- ADCT 5
- ONL 1
- Target Price
- ADCT $8.50
- ONL N/A
- AVG Volume (30 Days)
- ADCT 344.2K
- ONL 1.1M
- Earning Date
- ADCT 03-27-2025
- ONL 03-05-2025
- Dividend Yield
- ADCT N/A
- ONL 14.81%
- EPS Growth
- ADCT N/A
- ONL N/A
- EPS
- ADCT N/A
- ONL N/A
- Revenue
- ADCT $70,837,000.00
- ONL $164,122,000.00
- Revenue This Year
- ADCT $6.81
- ONL N/A
- Revenue Next Year
- ADCT $11.24
- ONL N/A
- P/E Ratio
- ADCT N/A
- ONL N/A
- Revenue Growth
- ADCT 1.84
- ONL N/A
- 52 Week Low
- ADCT $1.39
- ONL $2.10
- 52 Week High
- ADCT $5.38
- ONL $4.39
- Technical
- Relative Strength Index (RSI)
- ADCT 39.46
- ONL 22.60
- Support Level
- ADCT $1.41
- ONL $2.10
- Resistance Level
- ADCT $1.68
- ONL $2.29
- Average True Range (ATR)
- ADCT 0.12
- ONL 0.13
- MACD
- ADCT -0.03
- ONL 0.01
- Stochastic Oscillator
- ADCT 16.00
- ONL 13.64
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.